OPHTHALMIC
THERAPEUTICS

The first eye drops that prevent and treat early-stage diabetic retinopathy

MISSION

Eye icon

Our mission is to advance our portfolio to clinical trials and improve the lives of those affected by neurovascular ophthalmic pathologies.

ABOUT US

Retinset is a clinical-stage spin out from MEDICAL MIX with a purpose on providing new treatments in retinal pathologies. We have developed an innovative delivery solution to take drugs to the retina. Our leading program (BSL01) is a first-in-class eye drop formulation to treat Diabetic Retinopathy (DR) since very early stages. We have successfully completed a Phase I Clinical Trial.

RETINSET has the ability to bring an early-stage non-invasive cure to 144 million people suffering a severe life altering disease.